Annual CFF
-$4.19 M
-$3.07 M-272.71%
01 July 2024
Summary:
Enzo Biochem annual cash flow from financing activities is currently -$4.19 million, with the most recent change of -$3.07 million (-272.71%) on 01 July 2024. During the last 3 years, it has fallen by -$3.95 million (-1632.64%). ENZ annual CFF is now -107.29% below its all-time high of $57.50 million, reached on 31 July 2007.ENZ Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
-$3.61 M
-$3.56 M-8102.27%
01 July 2024
Summary:
Enzo Biochem quarterly cash flow from financing activities is currently -$3.61 million, with the most recent change of -$3.56 million (-8102.27%) on 01 July 2024. Over the past year, it has dropped by -$3.09 million (-596.72%). ENZ quarterly CFF is now -108.37% below its all-time high of $43.14 million, reached on 31 January 2007.ENZ Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
-$4.19 M
+$631.00 K+13.08%
01 July 2024
Summary:
Enzo Biochem TTM cash flow from financing activities is currently -$4.19 million, with the most recent change of +$631.00 thousand (+13.08%) on 01 July 2024. Over the past year, it has dropped by -$2.65 million (-170.87%). ENZ TTM CFF is now -107.26% below its all-time high of $57.77 million, reached on 31 October 2007.ENZ TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ENZ Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -272.7% | -596.7% | -170.9% |
| 3 y3 years | -1632.6% | -6231.6% | -2154.3% |
| 5 y5 years | -200.0% | -2010.5% | -203.4% |
ENZ Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -1639.8% | at low | -210.3% | +14.9% | -238.9% | +13.1% |
| 5 y | 5 years | -159.9% | at low | -149.3% | +14.9% | -159.4% | +13.1% |
| alltime | all time | -107.3% | at low | -108.4% | +14.9% | -107.3% | +13.1% |
Enzo Biochem Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| July 2024 | -$4.19 M(+272.7%) | -$3.61 M(+8102.3%) | -$4.19 M(-13.1%) |
| Apr 2024 | - | -$44.00 K(+100.0%) | -$4.82 M(+219.9%) |
| Jan 2024 | - | -$22.00 K(-95.8%) | -$1.51 M(-2.6%) |
| Oct 2023 | - | -$518.00 K(-87.8%) | -$1.55 M(+37.6%) |
| July 2023 | -$1.13 M(+366.8%) | -$4.24 M(-229.6%) | -$1.13 M(-137.3%) |
| Apr 2023 | - | $3.27 M(-5377.4%) | $3.02 M(-1163.0%) |
| Jan 2023 | - | -$62.00 K(-34.7%) | -$284.00 K(+1.8%) |
| Oct 2022 | - | -$95.00 K(-1.0%) | -$279.00 K(+15.8%) |
| July 2022 | -$241.00 K(-0.4%) | -$96.00 K(+209.7%) | -$241.00 K(+19.9%) |
| Apr 2022 | - | -$31.00 K(-45.6%) | -$201.00 K(+34.9%) |
| Jan 2022 | - | -$57.00 K(0.0%) | -$149.00 K(-19.9%) |
| Oct 2021 | - | -$57.00 K(+1.8%) | -$186.00 K(-23.1%) |
| July 2021 | -$242.00 K(-103.5%) | -$56.00 K(-366.7%) | -$242.00 K(-12.3%) |
| Apr 2021 | - | $21.00 K(-122.3%) | -$276.00 K(-103.9%) |
| Jan 2021 | - | -$94.00 K(-16.8%) | $7.02 M(-0.5%) |
| Oct 2020 | - | -$113.00 K(+25.6%) | $7.06 M(+0.8%) |
| July 2020 | $7.00 M(+67.0%) | -$90.00 K(-101.2%) | $7.00 M(+1.0%) |
| Apr 2020 | - | $7.32 M(<-9900.0%) | $6.93 M(-1509.3%) |
| Jan 2020 | - | -$58.00 K(-66.1%) | -$492.00 K(-112.1%) |
| Oct 2019 | - | -$171.00 K(+8.9%) | $4.06 M(-3.3%) |
| July 2019 | $4.19 M(+650.1%) | -$157.00 K(+48.1%) | $4.19 M(-4.2%) |
| Apr 2019 | - | -$106.00 K(-102.4%) | $4.38 M(-2.6%) |
| Jan 2019 | - | $4.49 M(<-9900.0%) | $4.50 M(<-9900.0%) |
| Oct 2018 | - | -$34.00 K(-225.9%) | -$32.00 K(-105.7%) |
| July 2018 | $559.00 K(-133.5%) | $27.00 K(+125.0%) | $559.00 K(-18.8%) |
| Apr 2018 | - | $12.00 K(-132.4%) | $688.00 K(+4.2%) |
| Jan 2018 | - | -$37.00 K(-106.6%) | $660.00 K(-146.6%) |
| Oct 2017 | - | $557.00 K(+257.1%) | -$1.42 M(-15.2%) |
| July 2017 | -$1.67 M(-13.6%) | $156.00 K(-1075.0%) | -$1.67 M(-30.0%) |
| Apr 2017 | - | -$16.00 K(-99.2%) | -$2.38 M(-32.8%) |
| Jan 2017 | - | -$2.11 M(-797.0%) | -$3.55 M(+136.1%) |
| Oct 2016 | - | $303.00 K(-154.1%) | -$1.50 M(-22.2%) |
| July 2016 | -$1.93 M(-131.0%) | -$560.00 K(-52.5%) | -$1.93 M(+27.3%) |
| Apr 2016 | - | -$1.18 M(+1659.7%) | -$1.52 M(-264.5%) |
| Jan 2016 | - | -$67.00 K(-46.4%) | $922.00 K(-76.3%) |
| Oct 2015 | - | -$125.00 K(-14.4%) | $3.89 M(-37.5%) |
| July 2015 | $6.22 M(-43.0%) | -$146.00 K(-111.6%) | $6.22 M(-25.6%) |
| Apr 2015 | - | $1.26 M(-56.6%) | $8.36 M(-32.1%) |
| Jan 2015 | - | $2.90 M(+31.6%) | $12.32 M(+10.4%) |
| Oct 2014 | - | $2.21 M(+10.7%) | $11.15 M(+2.2%) |
| July 2014 | $10.92 M(+126.7%) | $1.99 M(-61.8%) | $10.92 M(-21.6%) |
| Apr 2014 | - | $5.21 M(+199.0%) | $13.92 M(+61.7%) |
| Jan 2014 | - | $1.74 M(-11.5%) | $8.61 M(+26.4%) |
| Oct 2013 | - | $1.97 M(-60.6%) | $6.81 M(+41.5%) |
| July 2013 | $4.82 M(-3226.6%) | $5.00 M(-5049.5%) | $4.82 M(-2166.5%) |
| Apr 2013 | - | -$101.00 K(+83.6%) | -$233.00 K(+37.9%) |
| Jan 2013 | - | -$55.00 K(+96.4%) | -$169.00 K(+13.4%) |
| Oct 2012 | - | -$28.00 K(-42.9%) | -$149.00 K(-3.2%) |
| July 2012 | -$154.00 K(+126.5%) | -$49.00 K(+32.4%) | -$154.00 K(-11.0%) |
| Apr 2012 | - | -$37.00 K(+5.7%) | -$173.00 K(+27.2%) |
| Jan 2012 | - | -$35.00 K(+6.1%) | -$136.00 K(+34.7%) |
| Oct 2011 | - | -$33.00 K(-51.5%) | -$101.00 K(+48.5%) |
| July 2011 | -$68.00 K(<-9900.0%) | -$68.00 K(<-9900.0%) | -$68.00 K(<-9900.0%) |
| Apr 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jan 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| Oct 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| July 2010 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Oct 2009 | - | $0.00(0.0%) | $0.00(-100.0%) |
| July 2009 | $348.00 K(-24.0%) | $0.00(0.0%) | $348.00 K(-17.7%) |
| Apr 2009 | - | $0.00(0.0%) | $423.00 K(-2.5%) |
| Jan 2009 | - | $0.00(-100.0%) | $434.00 K(-5.0%) |
| Oct 2008 | - | $348.00 K(+364.0%) | $457.00 K(-0.2%) |
| July 2008 | $458.00 K(-99.2%) | $75.00 K(+581.8%) | $458.00 K(-22.4%) |
| Apr 2008 | - | $11.00 K(-52.2%) | $590.00 K(-96.0%) |
| Jan 2008 | - | $23.00 K(-93.4%) | $14.65 M(-74.6%) |
| Oct 2007 | - | $349.00 K(+68.6%) | $57.77 M(+0.5%) |
| July 2007 | $57.50 M | $207.00 K(-98.5%) | $57.50 M(+0.2%) |
| Apr 2007 | - | $14.07 M(-67.4%) | $57.39 M(+31.6%) |
| Jan 2007 | - | $43.14 M(>+9900.0%) | $43.61 M(+9258.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Oct 2006 | - | $79.00 K(-19.4%) | $466.00 K(+1.1%) |
| July 2006 | $461.00 K(+29.5%) | $98.00 K(-66.2%) | $461.00 K(+24.3%) |
| Apr 2006 | - | $290.00 K(<-9900.0%) | $371.00 K(+166.9%) |
| Jan 2006 | - | -$1000.00(-101.4%) | $139.00 K(-61.9%) |
| Oct 2005 | - | $74.00 K(+825.0%) | $365.00 K(+2.5%) |
| July 2005 | $356.00 K(-60.9%) | $8000.00(-86.2%) | $356.00 K(-11.9%) |
| Apr 2005 | - | $58.00 K(-74.2%) | $404.00 K(-40.5%) |
| Jan 2005 | - | $225.00 K(+246.2%) | $679.00 K(-2.4%) |
| Oct 2004 | - | $65.00 K(+16.1%) | $696.00 K(-23.5%) |
| July 2004 | $910.00 K(+44.3%) | $56.00 K(-83.2%) | $910.00 K(-37.7%) |
| Apr 2004 | - | $333.00 K(+37.6%) | $1.46 M(+29.5%) |
| Jan 2004 | - | $242.00 K(-13.3%) | $1.13 M(+27.3%) |
| Oct 2003 | - | $279.00 K(-54.1%) | $886.80 K(+40.6%) |
| July 2003 | $630.80 K(+1908.9%) | $607.80 K(>+9900.0%) | $630.80 K(+2716.1%) |
| Apr 2003 | - | $0.00(0.0%) | $22.40 K(-277.8%) |
| Jan 2003 | - | $0.00(-100.0%) | -$12.60 K(-158.9%) |
| Oct 2002 | - | $23.00 K(-3933.3%) | $21.40 K(-31.8%) |
| July 2002 | $31.40 K(-97.5%) | -$600.00(-98.3%) | $31.40 K(-87.5%) |
| Apr 2002 | - | -$35.00 K(-202.9%) | $250.90 K(-47.6%) |
| Jan 2002 | - | $34.00 K(+3.0%) | $478.90 K(-43.4%) |
| Oct 2001 | - | $33.00 K(-84.9%) | $845.90 K(-31.4%) |
| July 2001 | $1.23 M(-70.1%) | $218.90 K(+13.4%) | $1.23 M(-5.0%) |
| Apr 2001 | - | $193.00 K(-51.9%) | $1.30 M(-33.3%) |
| Jan 2001 | - | $401.00 K(-4.8%) | $1.95 M(-43.5%) |
| Oct 2000 | - | $421.00 K(+48.1%) | $3.45 M(-16.5%) |
| July 2000 | $4.13 M(+1963.1%) | $284.20 K(-66.2%) | $4.13 M(+4.7%) |
| Apr 2000 | - | $842.00 K(-55.7%) | $3.94 M(+27.2%) |
| Jan 2000 | - | $1.90 M(+72.7%) | $3.10 M(+138.5%) |
| Oct 1999 | - | $1.10 M(+1000.0%) | $1.30 M(+550.0%) |
| July 1999 | $200.00 K(-81.8%) | $100.00 K(>+9900.0%) | $200.00 K(-81.8%) |
| Apr 1999 | - | $0.00(-100.0%) | $1.10 M(0.0%) |
| Jan 1999 | - | $100.00 K(>+9900.0%) | $1.10 M(+10.0%) |
| Oct 1998 | - | $0.00(-100.0%) | $1.00 M(-9.1%) |
| July 1998 | $1.10 M(+22.2%) | $1.00 M(>+9900.0%) | $1.10 M(+120.0%) |
| Apr 1998 | - | $0.00(0.0%) | $500.00 K(-28.6%) |
| Jan 1998 | - | $0.00(-100.0%) | $700.00 K(-22.2%) |
| Oct 1997 | - | $100.00 K(-75.0%) | $900.00 K(0.0%) |
| July 1997 | $900.00 K(-43.8%) | $400.00 K(+100.0%) | $900.00 K(-10.0%) |
| Apr 1997 | - | $200.00 K(0.0%) | $1.00 M(+25.0%) |
| Jan 1997 | - | $200.00 K(+100.0%) | $800.00 K(-46.7%) |
| Oct 1996 | - | $100.00 K(-80.0%) | $1.50 M(-6.3%) |
| July 1996 | $1.60 M(-300.0%) | $500.00 K(>+9900.0%) | $1.60 M(+23.1%) |
| Apr 1996 | - | $0.00(-100.0%) | $1.30 M(-45.8%) |
| Jan 1996 | - | $900.00 K(+350.0%) | $2.40 M(+71.4%) |
| Oct 1995 | - | $200.00 K(0.0%) | $1.40 M(-275.0%) |
| July 1995 | -$800.00 K(-109.6%) | $200.00 K(-81.8%) | -$800.00 K(-11.1%) |
| Apr 1995 | - | $1.10 M(-1200.0%) | -$900.00 K(+800.0%) |
| Jan 1995 | - | -$100.00 K(-95.0%) | -$100.00 K(-92.9%) |
| Oct 1994 | - | -$2.00 M(-2100.0%) | -$1.40 M(-116.9%) |
| July 1994 | $8.30 M(+4050.0%) | $100.00 K(-94.7%) | $8.30 M(+1.2%) |
| Apr 1994 | - | $1.90 M(-235.7%) | $8.20 M(+30.2%) |
| Jan 1994 | - | -$1.40 M(-118.2%) | $6.30 M(-21.3%) |
| Oct 1993 | - | $7.70 M(>+9900.0%) | $8.00 M(+3900.0%) |
| July 1993 | $200.00 K(+100.0%) | $0.00(0.0%) | $200.00 K(-50.0%) |
| Apr 1993 | - | $0.00(-100.0%) | $400.00 K(0.0%) |
| Jan 1993 | - | $300.00 K(-400.0%) | $400.00 K(-233.3%) |
| Oct 1992 | - | -$100.00 K(-150.0%) | -$300.00 K(-400.0%) |
| July 1992 | $100.00 K(-107.7%) | $200.00 K(>+9900.0%) | $100.00 K(-107.7%) |
| Apr 1992 | - | $0.00(-100.0%) | -$1.30 M(0.0%) |
| Jan 1992 | - | -$400.00 K(-233.3%) | -$1.30 M(+30.0%) |
| Oct 1991 | - | $300.00 K(-125.0%) | -$1.00 M(-23.1%) |
| July 1991 | -$1.30 M(-68.3%) | -$1.20 M(<-9900.0%) | -$1.30 M(-67.5%) |
| Apr 1991 | - | $0.00(-100.0%) | -$4.00 M(-2.4%) |
| Jan 1991 | - | -$100.00 K(<-9900.0%) | -$4.10 M(0.0%) |
| Oct 1990 | - | $0.00(-100.0%) | -$4.10 M(0.0%) |
| July 1990 | -$4.10 M(<-9900.0%) | -$3.90 M(+3800.0%) | -$4.10 M(+1950.0%) |
| Apr 1990 | - | -$100.00 K(0.0%) | -$200.00 K(+100.0%) |
| Jan 1990 | - | -$100.00 K(<-9900.0%) | -$100.00 K(<-9900.0%) |
| Oct 1989 | - | $0.00 | $0.00 |
| July 1989 | $0.00 | - | - |
FAQ
- What is Enzo Biochem annual cash flow from financing activities?
- What is the all time high annual CFF for Enzo Biochem?
- What is Enzo Biochem annual CFF year-on-year change?
- What is Enzo Biochem quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Enzo Biochem?
- What is Enzo Biochem quarterly CFF year-on-year change?
- What is Enzo Biochem TTM cash flow from financing activities?
- What is the all time high TTM CFF for Enzo Biochem?
- What is Enzo Biochem TTM CFF year-on-year change?
What is Enzo Biochem annual cash flow from financing activities?
The current annual CFF of ENZ is -$4.19 M
What is the all time high annual CFF for Enzo Biochem?
Enzo Biochem all-time high annual cash flow from financing activities is $57.50 M
What is Enzo Biochem annual CFF year-on-year change?
Over the past year, ENZ annual cash flow from financing activities has changed by -$3.07 M (-272.71%)
What is Enzo Biochem quarterly cash flow from financing activities?
The current quarterly CFF of ENZ is -$3.61 M
What is the all time high quarterly CFF for Enzo Biochem?
Enzo Biochem all-time high quarterly cash flow from financing activities is $43.14 M
What is Enzo Biochem quarterly CFF year-on-year change?
Over the past year, ENZ quarterly cash flow from financing activities has changed by -$3.09 M (-596.72%)
What is Enzo Biochem TTM cash flow from financing activities?
The current TTM CFF of ENZ is -$4.19 M
What is the all time high TTM CFF for Enzo Biochem?
Enzo Biochem all-time high TTM cash flow from financing activities is $57.77 M
What is Enzo Biochem TTM CFF year-on-year change?
Over the past year, ENZ TTM cash flow from financing activities has changed by -$2.65 M (-170.87%)